サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：患者マッチングAI臨床試験ソリューションの世界市場（2022年～2030年）：市場シェア、規模、動向、業界分析、治療用途別、最終用途別、地域別、セグメント別予測
市場調査レポート
商品コード
1175497

患者マッチングAI臨床試験ソリューションの世界市場（2022年～2030年）：市場シェア、規模、動向、業界分析、治療用途別、最終用途別、地域別、セグメント別予測

AI-based Clinical Trial Solutions For Patient Matching Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Application; By End-Use (Pharmaceutical Companies, Academia, Others); By Region; Segment Forecast, 2022 - 2030
出版日: | 発行: Polaris Market Research | ページ情報: 英文 118 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
患者マッチングAI臨床試験ソリューションの世界市場（2022年～2030年）：市場シェア、規模、動向、業界分析、治療用途別、最終用途別、地域別、セグメント別予測
出版日: 2022年11月01日
発行: Polaris Market Research
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の患者マッチングAI臨床試験ソリューションの市場規模は、2030年までに19億6,900万米ドルになると予想されています。

当レポートでは、世界の患者マッチングAI臨床試験ソリューション市場を調査し、市場の概要、市場の促進要因・抑制要因の分析、市場機会、COVID-19の影響、セグメント別の市場分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 イントロダクション

  • レポートについて
    • 調査目的
    • 市場範囲
    • 前提条件
  • 利害関係者

第2章 エグゼクティブサマリー

  • 市場のハイライト

第3章 調査手法

  • 概要
    • データマイニング
  • データ情報源
    • 一次情報源
    • 二次情報源

第4章 世界の患者マッチングAI臨床試験ソリューション市場：洞察

  • 業界のスナップショット
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターのファイブフォース分析
    • 供給企業の交渉力（中）
    • 新規参入者の脅威（低）
    • 買い手の交渉力（中）
    • 代替の脅威（中）
    • 既存企業間の競争（高）
  • PESTLE分析
  • 業界の動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界の患者マッチングAI臨床試験ソリューション市場：治療用途別

  • 主な調査結果
  • イントロダクション
    • 治療用途別の世界市場（2018年～2030年）
  • 腫瘍
    • 腫瘍別、地域別
  • 心血管疾患
    • 心血管疾患別、地域別
  • 代謝疾患
    • 代謝疾患別、地域別
  • 神経疾患・症状
    • 神経疾患・症状別、地域別
  • 感染症
    • 感染症別、地域別
  • その他
    • その他別、地域別

第6章 世界の患者マッチングAI臨床試験ソリューション市場：最終用途別

  • 主な調査結果
  • イントロダクション
    • 最終用途別の世界市場（2018年～2030年）
  • 製薬会社
    • 製薬会社別、地域別
  • 学界
    • 学界別、地域別
  • その他
    • その他別、地域別

第7章 世界の患者マッチングAI臨床試験ソリューション市場：地域別

  • 主な調査結果
  • イントロダクション
    • 患者マッチングAI臨床試験ソリューション市場の評価：地域別（2018年～2030年）
  • 北米
    • 最終用途別
    • 治療用途別
    • 米国
    • カナダ
  • 欧州
    • 最終用途別
    • 治療用途別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
  • アジア太平洋地域
    • 最終用途別
    • 治療用途別
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
  • 中東・アフリカ
    • 最終用途別
    • 治療用途別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
  • ラテンアメリカ
    • 最終用途別
    • 治療用途別
    • メキシコ
    • ブラジル
    • アルゼンチン

第8章 競合情勢

  • 拡張と買収の分析
    • 拡張
    • 買収
  • パートナーシップ/コラボレーション/協定/展示会

第9章 企業プロファイル

  • Unlearn.AI, Inc
  • Antidote Technologies;Inc
  • Deep6.ai
  • Mendel.ai
  • Aris Global
  • Deep Lens
  • AmerisourceBergen Corporation
  • Koneksa
  • Microsoft Corporation
  • GNS Healthcare
図表

List of Tables

  • Table 1 Global AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 2 Global AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 3 AI-based Clinical Trial Solutions For Patient Matching Market Assessment, By Geography, 2018 - 2030 (USD Million)
  • Table 4 North America: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 5 North America: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 6 U.S.: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 7 U.S.: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 8 Canada: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 9 Canada: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 10 Europe: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 11 Europe: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 12 UK: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 13 UK: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 14 France: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 15 France: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 16 Germany: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 17 Germany: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 18 Italy: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 19 Italy: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 20 Spain: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 21 Spain: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 22 Netherlands: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 23 Netherlands: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 24 Russia: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 25 Russia: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 26 Asia Pacific: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 27 Asia Pacific: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 28 China: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 29 China: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 30 India: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 31 India: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 32 Malaysia: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 33 Malaysia: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 34 Japan: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 35 Japan: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 36 Indonesia: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 37 Indonesia: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 38 South Korea: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 39 South Korea: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 40 Middle East & Africa: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 41 Middle East & Africa: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 42 Saudi Arabia: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 43 Saudi Arabia: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 44 UAE: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 45 UAE: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 46 Israel: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 47 Israel: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 48 South Africa: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 49 South Africa: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 50 Latin America: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 51 Latin America: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 52 Mexico: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 53 Mexico: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 54 Brazil: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 55 Brazil: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • Table 56 Argentina: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 57 Argentina: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)

List of Figures

Figure 1 Global AI-based Clinical Trial Solutions For Patient Matching Market, 2018 - 2030 (USD Million)

Figure 2 Integrated Ecosystem

Figure 3 Research Methodology: Top-Down & Bottom-Up Approach

Figure 4 Market by Geography

Figure 5 Porter's Five Forces

Figure 6 Market by End-Use

Figure 7 Global AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2021 & 2030 (USD Million)

Figure 8 Market by Therapeutic Application

Figure 9 Global AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2021 & 2030 (USD Million)

Figure 10 AI-based Clinical Trial Solutions For Patient Matching Market Assessment, By Geography, 2018 - 2030 (USD Million)

Figure 11 Strategic Analysis - AI-based Clinical Trial Solutions For Patient Matching Market

目次
Product Code: PM2727

The global ai-based clinical trial solutions for patient matching market size is expected to reach USD 1,969 million by 2030, according to a new study by Polaris Market Research. The report "AI-based Clinical Trial Solutions For Patient Matching Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Application; By End-Use (Pharmaceutical Companies, Academia, Others); By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

With the dominance of branded products and the rising prevalence of diseases in the region, North America dominated the market in terms of revenue in 2021. Because of increased government and corporate investment in AI-based technologies to achieve higher efficiency and improve operational processes, as well as increased use of advanced technologies such as Artificial Intelligence (AI), Machine Learning (ML), and deep learning in clinical trials, the North America region dominates the global market share.

The United States is a significant contributor to the North American region. Other factors expected to contribute to the country's market growth include the presence of biopharmaceutical companies and ongoing oncology research to develop therapeutic drugs. In 2023, there will be approximately 37.3 million diabetics in the United States, including 28.7 million instances that have been diagnosed and 8.5 million cases that have not.

Europe is the second-largest market for AI-based Clinical Trials Solution Providers, trailed by the ASEAN region. Due to factors like growing geriatric and target populations, an increase in the number of collaborations for biosimilar development, geographic expansion of key players, and active participation of governmental and nonprofit organizations in the market space, Asia Pacific is predicted to experience significant growth during the forecast period.

Traditional R&D processes are time-consuming, costly, and require significant investment. Because of the high development costs, pharmaceutical and biotech companies are increasingly incorporating artificial intelligence (AI) into their research and development efforts in order to reduce costs, improve data quality, and shorten trial lengths.

Artificial intelligence (AI) and machine learning techniques are gradually improving clinical trial efficiencies, streamlining clinical practice processes, and enabling pharmaceutical companies to discover novel treatments and therapies more quickly and cost-effectively. This is expected to drive significant future growth in the global market.

An increase in the number of clinical studies, as well as increased government and private efforts to improve healthcare facilities through the adoption of novel AI technology and drugs, are driving market revenue growth.

Growing awareness of the benefits of AI-based clinical trials is expected to drive market revenue growth over the forecast period. Furthermore, wearable technology, in conjunction with AI techniques, is useful in real-time, individualized, and continuous monitoring of patients during trials. This can improve patient adherence to the protocol and the accuracy of the endpoint assessment.

Increasing the number of strategic alliances in the deployment of Artificial Intelligence (AI) in clinical trials in order to reduce time and expenditure during clinical development phases is expected to result in profitable market growth shortly.

Furthermore, regulators worldwide have issued guidelines encouraging biopharma companies to use real-world evidence strategies. For example, in 2019, the US FDA passed the 21st Century Cures Act, intended to help bring new innovations and advances to patients more efficiently and quickly. By providing faster insights to form decisions, using AI in clinical trials saves time and money. AI assists investigators in answering some questions, such as how to construct study designs, identify sites and patients for clinical research, and digitize adverse drug reactions.

AI-based Clinical Trial Solutions For Patient Matching Market Report Highlights

Oncology held the largest market share in therapeutic application segment due to rise in cancer cases which are a result of lifestyle changes.

Pharmaceutical companies held the largest market share in the end-use segment, which is a result of increasing drug targeting developments as an initiative of promising recovery.

North America dominated the market and is expected to witness significant growth in the forecast period due to enhancing AI startups. In addition, presence of biopharmaceutical companies and ongoing oncology research to develop therapeutic drugs spur regional growth.

The key players in the market are, Unlearn.AI, Inc.; Antidote Technologies; Inc.; Deep6.ai; Mendel.ai; Aris Global; Deep Lens; AmerisourceBergen Corporation; Koneksa; Microsoft Corporation; GNS Healthcare.

Polaris Market Research has segmented the AI-based clinical trial solutions for patient matching market report based on therapeutic applications, end-use and region:

AI-based Clinical Trial Solutions For Patient Matching, Therapeutic Applications Outlook (Revenue - USD Million, 2022 - 2030)

Oncology

Cardiovascular Diseases

Metabolic Diseases

Neurological Diseases or Conditions

Infectious Diseases

Others

AI-based Clinical Trial Solutions For Patient Matching, End-Use Outlook (Revenue - USD Million, 2022 - 2030)

Pharmaceutical Companies

Academia

Others

AI-based Clinical Trial Solutions For Patient Matching, Regional Outlook (Revenue - USD Million, 2022 - 2030)

North America

U.S

Canada

Europe

Germany

UK

France

Italy

Spain

Asia Pacific

Japan

China

India

Australia

South Korea

Latin America

Brazil

Mexico

Argentina

Middle East & Africa

South Africa

Saudi Arabia

UAE

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global AI-based Clinical Trial Solutions For Patient Matching Market Insights

  • 4.1. AI-based Clinical Trial Solutions For Patient Matching Market - Industry Snapshot
  • 4.2. AI-based Clinical Trial Solutions For Patient Matching Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increase in cross-industry alliances and collaborations
      • 4.2.1.2. Rising healthcare data volumes and dataset complexity
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Data privacy
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. AI-based Clinical Trial Solutions For Patient Matching Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • 5.3. Oncology
    • 5.3.1. Global AI-based Clinical Trial Solutions For Patient Matching Market, by Oncology, by Region, 2018 - 2030 (USD Million)
  • 5.4. Cardiovascular Diseases
    • 5.4.1. Global AI-based Clinical Trial Solutions For Patient Matching Market, by Cardiovascular Diseases, by Region, 2018 - 2030 (USD Million)
  • 5.5. Metabolic Diseases
    • 5.5.1. Global AI-based Clinical Trial Solutions For Patient Matching Market, by Metabolic Diseases, by Region, 2018 - 2030 (USD Million)
  • 5.6. Neurological Diseases or Conditions
    • 5.6.1. Global AI-based Clinical Trial Solutions For Patient Matching Market, by Neurological Diseases or Conditions, by Region, 2018 - 2030 (USD Million)
  • 5.7. Infectious Diseases
    • 5.7.1. Global AI-based Clinical Trial Solutions For Patient Matching Market, by Infectious Diseases, by Region, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Global AI-based Clinical Trial Solutions For Patient Matching Market, by Others, by Region, 2018 - 2030 (USD Million)

6. Global AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
  • 6.3. Pharmaceutical Companies
    • 6.3.1. Global AI-based Clinical Trial Solutions For Patient Matching Market, by Pharmaceutical Companies, by Region, 2018 - 2030 (USD Million)
  • 6.4. Academia
    • 6.4.1. Global AI-based Clinical Trial Solutions For Patient Matching Market, by Academia, by Region, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Global AI-based Clinical Trial Solutions For Patient Matching Market, by Others, by Region, 2018 - 2030 (USD Million)

7. Global AI-based Clinical Trial Solutions For Patient Matching Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. AI-based Clinical Trial Solutions For Patient Matching Market Assessment, By Geography, 2018 - 2030 (USD Million)
  • 7.3. AI-based Clinical Trial Solutions For Patient Matching Market - North America
    • 7.3.1. North America: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
    • 7.3.2. North America: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.3.3. AI-based Clinical Trial Solutions For Patient Matching Market - U.S.
      • 7.3.3.1. U.S.: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.3.3.2. U.S.: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.3.4. AI-based Clinical Trial Solutions For Patient Matching Market - Canada
      • 7.3.4.1. Canada: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.3.4.2. Canada: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • 7.4. AI-based Clinical Trial Solutions For Patient Matching Market - Europe
    • 7.4.1. Europe: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
    • 7.4.2. Europe: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.4.3. AI-based Clinical Trial Solutions For Patient Matching Market - UK
      • 7.4.3.1. UK: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.4.3.2. UK: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.4.4. AI-based Clinical Trial Solutions For Patient Matching Market - France
      • 7.4.4.1. France: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.4.4.2. France: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.4.5. AI-based Clinical Trial Solutions For Patient Matching Market - Germany
      • 7.4.5.1. Germany: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.4.5.2. Germany: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.4.6. AI-based Clinical Trial Solutions For Patient Matching Market - Italy
      • 7.4.6.1. Italy: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.4.6.2. Italy: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.4.7. AI-based Clinical Trial Solutions For Patient Matching Market - Spain
      • 7.4.7.1. Spain: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.4.7.2. Spain: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.4.8. AI-based Clinical Trial Solutions For Patient Matching Market - Netherlands
      • 7.4.8.1. Netherlands: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.4.8.2. Netherlands: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.4.9. AI-based Clinical Trial Solutions For Patient Matching Market - Russia
      • 7.4.9.1. Russia: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.4.9.2. Russia: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • 7.5. AI-based Clinical Trial Solutions For Patient Matching Market - Asia Pacific
    • 7.5.1. Asia Pacific: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
    • 7.5.2. Asia Pacific: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.5.3. AI-based Clinical Trial Solutions For Patient Matching Market - China
      • 7.5.3.1. China: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.5.3.2. China: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.5.4. AI-based Clinical Trial Solutions For Patient Matching Market - India
      • 7.5.4.1. India: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.5.4.2. India: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.5.5. AI-based Clinical Trial Solutions For Patient Matching Market - Malaysia
      • 7.5.5.1. Malaysia: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.5.5.2. Malaysia: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.5.6. AI-based Clinical Trial Solutions For Patient Matching Market - Japan
      • 7.5.6.1. Japan: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.5.6.2. Japan: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.5.7. AI-based Clinical Trial Solutions For Patient Matching Market - Indonesia
      • 7.5.7.1. Indonesia: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.5.7.2. Indonesia: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.5.8. AI-based Clinical Trial Solutions For Patient Matching Market - South Korea
      • 7.5.8.1. South Korea: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.5.8.2. South Korea: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • 7.6. AI-based Clinical Trial Solutions For Patient Matching Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
    • 7.6.2. Middle East & Africa: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.6.3. AI-based Clinical Trial Solutions For Patient Matching Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.6.3.2. Saudi Arabia: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.6.4. AI-based Clinical Trial Solutions For Patient Matching Market - UAE
      • 7.6.4.1. UAE: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.6.4.2. UAE: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.6.5. AI-based Clinical Trial Solutions For Patient Matching Market - Israel
      • 7.6.5.1. Israel: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.6.5.2. Israel: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.6.6. AI-based Clinical Trial Solutions For Patient Matching Market - South Africa
      • 7.6.6.1. South Africa: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.6.6.2. South Africa: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • 7.7. AI-based Clinical Trial Solutions For Patient Matching Market - Latin America
    • 7.7.1. Latin America: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
    • 7.7.2. Latin America: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.7.3. AI-based Clinical Trial Solutions For Patient Matching Market - Mexico
      • 7.7.3.1. Mexico: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.7.3.2. Mexico: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.7.4. AI-based Clinical Trial Solutions For Patient Matching Market - Brazil
      • 7.7.4.1. Brazil: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.7.4.2. Brazil: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 7.7.5. AI-based Clinical Trial Solutions For Patient Matching Market - Argentina
      • 7.7.5.1. Argentina: AI-based Clinical Trial Solutions For Patient Matching Market, by End-Use, 2018 - 2030 (USD Million)
      • 7.7.5.2. Argentina: AI-based Clinical Trial Solutions For Patient Matching Market, by Therapeutic Application, 2018 - 2030 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Unlearn.AI, Inc
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Antidote Technologies; Inc
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Deep6.ai
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Mendel.ai
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Aris Global
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Deep Lens
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. AmerisourceBergen Corporation
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Koneksa
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Microsoft Corporation
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. GNS Healthcare
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development